Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models
Article in Frontiers in Oncology (January 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma
Article in Cancer Letters (December 2022)
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
Article in Genes & Diseases (May 2022)